UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000058684 |
|---|---|
| Receipt number | R000067102 |
| Scientific Title | Study on eosinophil surface antigens in COPD |
| Date of disclosure of the study information | 2025/08/04 |
| Last modified on | 2025/08/04 06:22:11 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Study on eosinophil surface antigens in non-asthmatic chronic obstructive pulmonary disease (COPD)
Acronym
Study on eosinophil surface antigens in COPD
Scientific Title
Study on eosinophil surface antigens in COPD
Scientific Title:Acronym
Study on eosinophil surface antigens in COPD
Region
| Japan |
Condition
Condition
non-asthmatic chronic obstructive pulmonary disease (COPD)
Classification by specialty
| Pneumology |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To verify whether the ratio of inflammatory eosinophils/non-activated (resident) eosinophils classified by eosinophil surface antigens is related to the clinical pathology and treatment of pure COPD.
Basic objectives2
Bio-availability
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Proportion of patients with eosinophilia among those with non-asthmatic chronic obstructive pulmonary disease (COPD)
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 40 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Chronic obstructive pulmonary disease (COPD)
Key exclusion criteria
asthma
Target sample size
100
Research contact person
Name of lead principal investigator
| 1st name | Tomotaka |
| Middle name | |
| Last name | Kawayama |
Organization
Kurume university
Division name
Department of medicine
Zip code
8300011
Address
67 Asahi-machi, Kurume
TEL
0942317560
kawayama_tomotaka@med.kurume-u.ac.jp
Public contact
Name of contact person
| 1st name | Tomoataka |
| Middle name | |
| Last name | Kawayama |
Organization
Kurume University
Division name
Department of medicine
Zip code
8300011
Address
67 Asahi-machi, Kurume
TEL
0942317560
Homepage URL
kawayama_tomotaka@med.kurume-u.ac.jp
Sponsor or person
Institute
Kurume University
Institute
Department
Personal name
Funding Source
Organization
Kurume University
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Kurume University Clinical Research Center
Address
67 Asahi-machi, Kurume
Tel
0942317200
i_rinri@kurume-u.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2025 | Year | 08 | Month | 04 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Enrolling by invitation
Date of protocol fixation
| 2025 | Year | 07 | Month | 23 | Day |
Date of IRB
| 2025 | Year | 07 | Month | 23 | Day |
Anticipated trial start date
| 2025 | Year | 08 | Month | 04 | Day |
Last follow-up date
| 2026 | Year | 12 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Some of the clinical specimens obtained at Kurume University will be tested at Akita University.
Management information
Registered date
| 2025 | Year | 08 | Month | 04 | Day |
Last modified on
| 2025 | Year | 08 | Month | 04 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067102
